LATEST ALERTS
The South Korean legislation does not make a clear distinction between hemp and cannabis. This report provides a detailed overview of the regulatory framework in place for hemp, cannabinoids and cannabis, covering all policy areas
This report provides a detailed overview of the current regulatory framework in place in Lebanon for hemp, cannabinoids such as CBD, and cannabis
Cannabis and cannabis extracts are controlled substances under national legislation in China. This report provides a detailed overview of national and local regulation of hemp, CBD and cannabis
This report provides a detailed overview of the regulatory framework in place in Hong Kong for hemp, cannabis and CBD
This report provides a detailed overview of the current regulatory framework in place for CBD, hemp and cannabis in Taiwan, covering all policy areas from cultivation and processing to extracts, finished products and import/export
This report offers a detailed overview of Japan’s regulatory regime for cannabis, CBD and hemp, covering all policy areas and discussing future changes to the law
CBD is no longer considered a scheduled substance and will be allowed in foods and cosmetics once the Ministry of Health permits it
CBD-Intel has compiled and classified regulatory data on medical and recreational cannabis in over 50 jurisdictions around the world. This report is accompanied by a detailed database outlining the regulatory situation in selected countries
This report offers a regulatory overview of hemp and CBD in China, covering mainland China, as well as provincial regulations in Yunnan and Heilongjiang
Hemp flowers are treated similarly in Europe to all other hemp-derived CBD products in that market restrictions differ from country to country
This report provides an overview of the current regulations for import and export of hemp, cannabis and CBD products in China
This report provides an overview of the regulatory regime for CBD, hemp and cannabis in Taiwan
A debate on regulating cannabis for medicinal use is on the table in the Philippines, and several bills are currently being discussed. This report provides an overview of the current regulatory regime for CBD and cannabis in the country
Singapore has a tough regime for hemp products. This report offers an overview of said regime, covering all areas of law
This regulatory report covers all aspects of the regulatory regime for hemp and CBD in Japan, including medical cannabis and import/export laws
This report investigates the current situation with respect to advertising CBD products via the most widely used social media platforms
Jilin province is the third province in China to be actively working on hemp regulation. This report offers an analysis on the potential upcoming regulations, looking at all aspects from imports to cultivation
This report provides an overview of the current regulatory landscape for CBD and hemp in Hong Kong, including analysis of the restrictions relating to medical and recreational cannabis
This report offers our analysis of the regulatory regime in South Korea for CBD and related products, including extracts and finished products, their import and export, and medical and recreational cannabis
The legal framework and licencing regime are not fully in place yet in Thailand, and the overall regulations – which affect sales, imports, exports and possession of hemp and cannabis extracts – are restrictive
Malaysia has a tough regime on hemp products. Cultivation is prohibited because hemp falls into the cannabis legal framework. The previous government had started to look into the possibility of legalising hemp cultivation and processing
The CBD industry navigates a complex and changing regulatory landscape across the world, with parts of the industry operating in a grey area. This is particularly the case for one of the most popular product categories on the market: edibles
The regulatory landscape for CBD products varies across the world and constantly changing, making compliance a potential minefield. This report provides an overview of the current legal status of CBD cosmetics in key markets around the world
In our look at the regulatory picture in India we find that while CBD is regulated at a federal level, states also have their own rules and regulations with some more lenient than others
Japanese law is easygoing on some aspects of the CBD market and very strict on others, as a result of the country’s rigorous regulation of cannabis
CBD-Intel’s report on the regulatory status of CBD in China provides all you need to know about the present legal status of CBD, plus hemp cultivation and much more
As regulations in China continue to evolve, we look at developments in the third Chinese province to consider new regulations for industrialised hemp
While no product-specific regulation covers CBD products in Hong Kong, this report examines the rules that apply to their import, export, production and sale in the territory
China’s highest anti-drug agency, the National Narcotics Control Commission, is reported to have issued a “Notice on strengthening regulation of industrial hemp”
Our latest regulatory report on CBD in Israel covers the hemp plant’s status, the import and export of finished product and much more.
Cannabis is a dangerous drug under Israeli criminal law; the possibility of legalising industrial hemp is presently being explored by the government. The legality of CBD products imported and distributed in Israel remains a grey area; the Ministry of Health considers CBD a dangerous drug while the police have declared it legal – while also decriminalising cannabis…
CannIntelligence.com provides independent, in-depth regulatory and market data and intelligence for the global cannabis and cannabinoid sector.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
